Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on Isoniazid-Induced Hepatotoxicity: Incidence, Risk Factors and Therapeutic Strategies

NCT07472348 is registered in ClinicalTrials.gov with ASST Fatebenefratelli Sacco as lead sponsor.

NCT NCT07472348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07472348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on Isoniazid-Induced Hepatotoxicity: Incidence, Risk Factors and Therapeutic Strategies
Lead sponsor
ASST Fatebenefratelli Sacco
Phase
Observational
Overall status
Not yet recruiting
Start date
May 30, 2026
Completion date
September 1, 2026
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis infection, tuberculosis infection, latent